Double primary malignancy in colorectal cancer patients--MSI is the useful marker for predicting double primary tumors.
OBJECTIVE
The incidence of double primary malignancies (DPM) is known to be higher in colorectal cancer patients than the general population. And, the role of microsatellite instability (MSI) in DPM has been previously studied. We evaluated the clinical features and association between MSI and colorectal cancer patients with DPM.


METHODS
From September 1994 to May 2004, we reviewed 2,301 colorectal cancer patients with regard to secondary primary malignancies. A subgroup analysis was performed for MSI after January 2003.


RESULTS
One hundred forty-five patients (6.3%) had a DPM identified. In DPM group, 57 patients had a synchronous DPM (39.3%), and 88 patients had a metachronous malignancy (60.7%). Male gender (p<0.001) and colon cancer (p<0.001) were the factors related with the development of the DPM. Most of the second malignancies occurred within 3 years after the primary operation. The common second malignancies were stomach (58 patients, 40%) and lung (21 patients, 14.5%). In the subgroup analysis, there was a higher frequency of DPM in the MSI group when compared to the microsatellite stable group (p=0.021).


CONCLUSIONS
The careful pre- and postoperative evaluation should be paid for detecting DPM as well as for detecting recurrence in colorectal cancer patients. The results of this study suggest that MSI might be a useful marker for the detection of DPM in colorectal cancer patients.
Yun
H R
HR
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-dong 50, Gangnam-gu, Seoul 135-710, South Korea.
Yi
L J
LJ
Cho
Y K
YK
Park
J H
JH
Cho
Y B
YB
Yun
S H
SH
Kim
H C
HC
Chun
H K
HK
Lee
W Y
WY
D015179:Colorectal Neoplasms / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D053842:Microsatellite Instability; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000235:genetics*; D013274:Stomach Neoplasms / Q000556:secondary; D016019:Survival Analysis; D013997:Time Factors
D005819:Genetic Markers
Cancer Res. 1998 Nov 15;58(22):5248-57
9823339
Ann Surg. 1982 Apr;195(4):501-7
7065754
Cancer. 2006 Sep 1;107(5 Suppl):1162-71
16838312
Cancer Res. 1993 Nov 1;53(21):5100-3
8221644
Mod Pathol. 1999 Jan;12(1):15-20
9950157
Dis Colon Rectum. 1998 Jun;41(6):765-9
9645746
Gut. 2002 May;50(5):647-52
11950810
Nat Med. 1996 Feb;2(2):169-74
8574961
Mod Pathol. 2001 Jun;14(6):543-8
11406654
Cancer Res. 1993 Nov 1;53(21):5087-9
8221640
Int J Clin Oncol. 2003 Jun;8(3):162-7
12851840
Dis Colon Rectum. 1991 May;34(5):424-5
2022152
Lung Cancer. 2002 Feb;35(2):189-94
11804692
J Natl Cancer Inst. 1984 May;72(5):1021-7
6585580
IARC Sci Publ. 2004;(157):289-97
15055302
Jpn J Cancer Res. 1994 Apr;85(4):339-45
8200845
Surg Today. 1992;22(2):99-104
1498501
Cancer Res. 1994 Jul 1;54(13):3373-5
8012952
Am J Clin Oncol. 2003 Aug;26(4):386-91
12902892
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
16514137
Oncology. 2003;65(2):113-7
12931016
Cancer Causes Control. 2005 Jun;16(5):475-81
15986102
Dis Colon Rectum. 2006 Oct;49(10 Suppl):S30-6
17106813
Int J Cancer. 2001 Jun 15;92(6):883-7
11351311
Cancer. 1999 May 1;85(9):1917-24
10223230
Int J Cancer. 2000 Jun 1;86(5):678-83
10797290